JP2012097013A - Blood circulation promoting aerosol composition - Google Patents
Blood circulation promoting aerosol composition Download PDFInfo
- Publication number
- JP2012097013A JP2012097013A JP2010244906A JP2010244906A JP2012097013A JP 2012097013 A JP2012097013 A JP 2012097013A JP 2010244906 A JP2010244906 A JP 2010244906A JP 2010244906 A JP2010244906 A JP 2010244906A JP 2012097013 A JP2012097013 A JP 2012097013A
- Authority
- JP
- Japan
- Prior art keywords
- blood circulation
- skin
- aerosol composition
- circulation promoting
- carbon dioxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000443 aerosol Substances 0.000 title claims abstract description 65
- 239000000203 mixture Substances 0.000 title claims abstract description 51
- 230000017531 blood circulation Effects 0.000 title claims abstract description 47
- 230000001737 promoting effect Effects 0.000 title claims abstract description 38
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 100
- 239000001569 carbon dioxide Substances 0.000 claims abstract description 50
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 50
- 239000006260 foam Substances 0.000 claims abstract description 50
- 239000011550 stock solution Substances 0.000 claims abstract description 31
- 239000004094 surface-active agent Substances 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000002562 thickening agent Substances 0.000 claims abstract description 14
- 239000003380 propellant Substances 0.000 claims description 8
- 238000005507 spraying Methods 0.000 claims description 6
- 230000007794 irritation Effects 0.000 abstract description 10
- 230000005660 hydrophilic surface Effects 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000007789 gas Substances 0.000 description 30
- 239000003921 oil Substances 0.000 description 21
- 235000019198 oils Nutrition 0.000 description 21
- 238000011010 flushing procedure Methods 0.000 description 15
- -1 fatty acid ester Chemical class 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 11
- 239000003915 liquefied petroleum gas Substances 0.000 description 9
- 206010040880 Skin irritation Diseases 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- 230000036556 skin irritation Effects 0.000 description 7
- 231100000475 skin irritation Toxicity 0.000 description 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 239000003570 air Substances 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000001139 pH measurement Methods 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 230000024883 vasodilation Effects 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- XATHTZNVYDUDGS-UHFFFAOYSA-N 2-octadecylpropane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCCCC(O)(CO)CO XATHTZNVYDUDGS-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 150000005168 4-hydroxybenzoic acids Chemical class 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229930182556 Polyacetal Natural products 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940080313 sodium starch Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229940071117 starch glycolate Drugs 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 239000005028 tinplate Substances 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
本発明は、炭酸ガスを配合したエアゾール組成物であって、更に詳しくは、炭酸ガスを配合することによって血行促進効果を発揮するエアゾール組成物に関する。 The present invention relates to an aerosol composition containing carbon dioxide, and more particularly to an aerosol composition that exhibits a blood circulation promoting effect by adding carbon dioxide.
従来より、炭酸ガスの血行促進作用を利用した提案は数多くされている。例えば、特許文献1では、炭酸ガス難透過性の包装ピロー内に、炭酸ガスとともにシート状貼付剤を密閉してなる身体貼布用シート材であって、そのシート状貼付剤を構成する液又はゲルの溶存炭酸ガス量やpH、包装ピローに対する充填比を調整することによって、保存時の炭酸ガスの揮散を防止し、かつ使用時の炭酸ガスの揮散を抑えつつ皮膚に血行促進効果を付与する身体貼布用シート材が提案されている。しかしながら、この身体貼布用シート材を実際に製造することはかなり困難である。 Conventionally, many proposals using the blood circulation promoting action of carbon dioxide have been made. For example, in Patent Document 1, a sheet material for body patch, in which a sheet-like patch is sealed together with carbon dioxide in a carbon dioxide-poor packaging pillow, the liquid constituting the sheet-like patch or By adjusting the amount of dissolved carbon dioxide and pH of the gel, and the packing ratio to the packaging pillow, it prevents the volatilization of carbon dioxide during storage and gives blood circulation promoting effects to the skin while suppressing the volatilization of carbon dioxide during use. Body sheet materials have been proposed. However, it is quite difficult to actually manufacture this body-applied sheet material.
炭酸ガスを配合したエアゾール組成物についても数多く提案されている。特許文献2では血行促進剤を含有する養毛・育毛料に、特許文献3では水性化粧料に、特許文献4では多価アルコールにそれぞれ血管拡張作用を有する炭酸ガスを配合したエアゾール組成物が提案されているが、皮膚に塗布した際の血管拡張作用に伴う皮膚紅潮は確認されていない。また、特許文献4においては、化粧料に粘度を持たせて炭酸ガスの残留性を高くさせた提案もされているが、化粧料が高粘度の場合には、二重構造のエアゾール容器を用いる必要があり、コストが高くなるという問題もある。 Many aerosol compositions containing carbon dioxide have also been proposed. Patent Document 2 proposes an aerosol composition containing a blood circulation promoter containing a blood circulation promoter, Patent Document 3 an aqueous cosmetic, and Patent Document 4 a polyalcohol blended with carbon dioxide having vasodilatory action. However, skin flushing associated with vasodilation when applied to the skin has not been confirmed. Further, in Patent Document 4, there is also a proposal for increasing the viscosity of the cosmetic material to increase the carbon dioxide gas persistence, but when the cosmetic material has a high viscosity, a double-structure aerosol container is used. There is also a problem that it is necessary and the cost becomes high.
また、特許文献5は特定の非イオン界面活性剤、低粘度の油剤、エタノール、水の比率一定量比とすることで炭酸ガスの残留性を高めたエアゾール組成物が提案されているが、必須成分にエタノールを20%以上含有するため皮膚に長時間塗布したときに強い刺激が感じられるほか、血管拡張作用に伴う皮膚紅潮は確認されていない。特許文献6は親油性界面活性剤、油成分、水からなる乳化原液と炭酸ガスを含む圧縮ガスからなるエアゾール組成物が提案されているが、この組成物から形成された泡は硬いため、その泡を皮膚に塗布しても炭酸ガスが皮膚へ浸透しにくく炭酸ガスによる血行促進効果は得られない。特許文献7、8では炭酸ガスを皮膚上に長時間作用させて皮膚紅潮及び血行促進効果が得られる泡沫状皮膚塗布剤が提案されているが、必須成分に炭素数が3〜5から選ばれる炭化水素が含まれるため、この泡沫状皮膚塗布剤から形成された泡を皮膚に塗布した場合の皮膚刺激性は強いものであり、また、上記の炭化水素を配合せず炭酸ガスのみを配合した比較例(特許文献7においては比較例2、特許文献8においては比較例1)においては、泡を形成するがだれてしまい皮膚の上で安定なものではなかった。 In addition, Patent Document 5 proposes an aerosol composition in which carbon dioxide gas persistence is improved by setting a specific ratio of a specific nonionic surfactant, a low-viscosity oil, ethanol, and water, but is essential. In addition to containing 20% or more of ethanol as a component, strong irritation is felt when applied to the skin for a long time, and skin flushing associated with vasodilation has not been confirmed. Patent Document 6 proposes an aerosol composition composed of a lipophilic surfactant, an oil component, an emulsified stock solution composed of water and a compressed gas containing carbon dioxide gas, but the foam formed from this composition is hard, so that Even if foam is applied to the skin, the carbon dioxide gas hardly penetrates into the skin, and the blood circulation promotion effect by the carbon dioxide gas cannot be obtained. In Patent Documents 7 and 8, a foamy skin coating agent is proposed in which carbon dioxide gas is allowed to act on the skin for a long period of time to obtain skin flushing and blood circulation promoting effects, but the essential component is selected from 3 to 5 carbon atoms. Since hydrocarbons are included, the skin irritation when foam formed from this foamy skin coating agent is applied to the skin is strong, and the above hydrocarbons are not blended and only carbon dioxide is blended. In the comparative example (Comparative Example 2 in Patent Document 7 and Comparative Example 1 in Patent Document 8), foam was formed but was not stable on the skin.
本願発明はこのことに鑑み、簡単に使用でき、形成される泡の状態が良好で皮膚へ塗布した際に皮膚への刺激がなく、良好な泡状態が維持される間に塗布部位に対して優れた血行促進効果を発揮する血行促進エアゾール組成物を提供することを課題とする。より望ましくは、血行促進効果が皮膚紅潮等のように容易に視認されうる血行促進エアゾール組成物の提供を図らんとするものである。 In view of this, the present invention can be used easily, and the state of the foam formed is good, there is no irritation to the skin when applied to the skin, and while the good foam state is maintained, It is an object of the present invention to provide a blood circulation promoting aerosol composition that exhibits an excellent blood circulation promoting effect. More desirably, it is intended to provide a blood circulation promoting aerosol composition whose blood circulation promoting effect can be easily visually recognized such as skin flushing.
上記課題を解決するために、本願の請求項1に記載の発明は、水、親水性界面活性剤、増粘剤、油成分を含む原液と、炭酸ガスとをエアゾール用バルブ及びノズルを備えた耐圧容器に封入してなるエアゾール組成物において、上記耐圧容器からの噴射により形成された泡を皮膚に塗布した後、20秒以内に皮膚と接触した箇所の泡が消泡し始め、少なくとも1分間は泡状態を維持するものであり、その泡状態が維持される間に塗布部位に対して血行促進効果を発揮することを特徴とする血行促進エアゾール組成物を提供する。 In order to solve the above-mentioned problems, the invention according to claim 1 of the present application is provided with an aerosol valve and a nozzle for water, a hydrophilic surfactant, a thickener, a stock solution containing an oil component, and carbon dioxide. In the aerosol composition sealed in a pressure vessel, after the foam formed by spraying from the pressure vessel is applied to the skin, the bubbles coming into contact with the skin within 20 seconds start to disappear, and for at least 1 minute Is for maintaining a foam state, and provides a blood circulation promoting aerosol composition characterized by exerting a blood circulation promoting effect on an application site while the foam state is maintained.
また、本願の請求項2に記載の発明は、上記親水性界面活性剤のHLBが10〜19であり、かつ上記原液中の上記親水性界面活性剤含有量が0.1〜15重量%であり、上記原液中の上記油成分含有量が3〜30重量%であり、上記エアゾール組成物中の上記炭酸ガス含有量が500〜5000ppmであることを特徴とする請求項1に記載の血行促進エアゾール組成物を提供する。 In the invention according to claim 2 of the present application, the hydrophilic surfactant has an HLB of 10 to 19, and the hydrophilic surfactant content in the stock solution is 0.1 to 15% by weight. 2. The blood circulation promotion according to claim 1, wherein the oil component content in the stock solution is 3 to 30 wt%, and the carbon dioxide gas content in the aerosol composition is 500 to 5000 ppm. An aerosol composition is provided.
また、本願の請求項3に記載の発明は、上記エアゾール組成物の噴射剤が、上記炭酸ガスのみから構成されていることを特徴とする請求項2に記載の血行促進エアゾール組成物を提供する。 The invention according to claim 3 of the present application provides the blood circulation promoting aerosol composition according to claim 2, wherein the propellant of the aerosol composition is composed of only the carbon dioxide gas. .
また、本願の請求項4に記載の発明は、上記原液の粘度が、20℃において50〜500mPa・sであることを特徴とする請求項1〜3の何れかに記載の血行促進エアゾール組成物を提供する。 The invention according to claim 4 of the present application is characterized in that the viscosity of the stock solution is 50 to 500 mPa · s at 20 ° C., and the blood circulation promoting aerosol composition according to any one of claims 1 to 3 I will provide a.
本願発明は、水、親水性界面活性剤、増粘剤、油成分を含む原液と、炭酸ガスとをエアゾール用バルブ及びノズルを備えた耐圧容器に封入することにより、上記耐圧容器からの噴射により良好な泡を形成し、その泡を皮膚に塗布した際に皮膚への刺激もなく、塗布後炭酸ガスを含む泡が少なくとも1分間は維持され、その泡状態が維持される間に塗布部位に対して炭酸ガスによる優れた血行促進効果を発揮する血行促進エアゾール組成物を提供することができたものである。 The invention of the present application includes a stock solution containing water, a hydrophilic surfactant, a thickener, an oil component, and carbon dioxide gas in a pressure-resistant container equipped with an aerosol valve and a nozzle. Forms good foam, there is no irritation to the skin when the foam is applied to the skin, and the foam containing carbon dioxide gas is maintained for at least 1 minute after application, while the foam state is maintained at the application site In contrast, the present invention has been able to provide a blood circulation promoting aerosol composition that exhibits an excellent blood circulation promoting effect of carbon dioxide.
以下、本願発明に係る血行促進エアゾール組成物について説明する。 Hereinafter, the blood circulation promoting aerosol composition according to the present invention will be described.
本願発明に係る血行促進エアゾール組成物は、水、親水性界面活性剤、増粘剤、油成分を含む原液と、炭酸ガスとをエアゾール用バルブ及びノズルを備えた耐圧容器に封入してなる組成物である。以下、水、親水性界面活性剤、増粘剤、油成分を含む原液を水性原液と称する。 The blood circulation promoting aerosol composition according to the present invention is a composition in which water, a hydrophilic surfactant, a thickener, a stock solution containing an oil component, and carbon dioxide gas are enclosed in a pressure-resistant container having an aerosol valve and a nozzle. It is a thing. Hereinafter, a stock solution containing water, a hydrophilic surfactant, a thickener, and an oil component is referred to as an aqueous stock solution.
本願発明に係る血行促進エアゾール組成物には、水が配合される。この水は通常エアゾール組成物に用いられる水であれば特に制限されず、例えば、精製水、イオン交換水、蒸留水などが挙げられる。 The blood circulation promoting aerosol composition according to the present invention contains water. The water is not particularly limited as long as it is usually used in an aerosol composition, and examples thereof include purified water, ion exchange water, and distilled water.
本願発明に係る血行促進エアゾール組成物には、親水性界面活性剤が配合される。この親水性界面活性剤は、上記水に後述する油成分を乳化させるものである。
この親水性界面活性剤としては、例えばポリグリセリン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリエチレングリコール脂肪酸エステル、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンポリオキシプロピレンアルキルエーテル、ポリオキシエチレンソルビット脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンラノリンアルコールなどが挙げられ、その親水性・新油性バランス(以下、HLBとする)が10〜19、好ましくは12〜19、更に好ましくは14〜18の範囲のものである。HLBが10未満であると良好な泡状態を形成しない。これらの親水性界面活性剤は、1種または2種以上を組み合わせて用いることができる。また、比較的高いHLBを有する親水性界面活性剤と、比較的低いHLBを有する親水性界面活性剤とを混合して用いてもよい。
A hydrophilic surfactant is blended in the blood circulation promoting aerosol composition according to the present invention. This hydrophilic surfactant emulsifies the oil component described later in the water.
Examples of the hydrophilic surfactant include polyglycerin fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyethylene glycol fatty acid ester, polyoxyethylene alkyl ether, polyoxyethylene polyoxypropylene alkyl ether, polyoxyethylene sorbite fatty acid ester, Examples thereof include oxyethylene glycerin fatty acid ester, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, polyoxyethylene lanolin alcohol, and the like. The hydrophilic / new oil balance (hereinafter referred to as HLB) is 10 to 19, preferably It is in the range of 12-19, more preferably 14-18. When the HLB is less than 10, a good foam state is not formed. These hydrophilic surfactants can be used alone or in combination of two or more. Further, a hydrophilic surfactant having a relatively high HLB and a hydrophilic surfactant having a relatively low HLB may be mixed and used.
また、これらの親水性界面活性剤の含有量は、後述する油成分を充分に乳化するために、水性原液に対して0.1〜15重量%の範囲が好ましく、水性原液に対して2〜10重量%の範囲がより好ましい。 Moreover, in order to fully emulsify the oil component mentioned later, the content of these hydrophilic surfactants is preferably in the range of 0.1 to 15% by weight with respect to the aqueous stock solution, and 2 to 2 with respect to the aqueous stock solution. A range of 10% by weight is more preferred.
本願発明に係る血行促進エアゾール組成物には、水性原液の粘度を調整するための増粘剤が配合される。
この増粘剤としては、特に限定されないが、例えばポリアクリル系樹脂、ポリビニル系樹脂、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、アルギン酸ナトリウム、アルギン酸プロピレングリコールエステル、カルボキシメチルセルロースエステル、カルボキシメチルセルロースナトリウム、デンプンリン酸エステルナトリウム、デンプングリコール酸ナトリウム、メチルセルロース、ポリアクリル酸ナトリウム、セルロースエステル、アルギン酸、カゼイン、グアーガム、グルテン、デンプンなどが挙げられる。これらの増粘剤は1種または2種以上を組み合わせて用いることができる。
The blood circulation promoting aerosol composition according to the present invention is mixed with a thickener for adjusting the viscosity of the aqueous stock solution.
The thickener is not particularly limited, but for example, polyacrylic resin, polyvinyl resin, hydroxyethyl cellulose, hydroxypropyl cellulose, sodium alginate, propylene glycol alginate, carboxymethyl cellulose ester, sodium carboxymethyl cellulose, sodium starch phosphate , Starch glycolate, methylcellulose, sodium polyacrylate, cellulose ester, alginic acid, casein, guar gum, gluten, starch and the like. These thickeners can be used alone or in combination of two or more.
また、20℃における水性原液の粘度は、50〜500mPa・sの範囲が好ましく、更に好ましくは200〜300mPa・sの範囲である。粘度が500mPa・sを超えると容器内に付着した内容物が最後まで吐出せず、残量が多くなる。また、粘度が50mPa・s未満であると、水性原液と炭酸ガスとが封入されたエアゾール用バルブ及びノズルを備えた耐圧容器からの噴射により形成された泡を皮膚に塗布した時に泡が垂れ落ち、良好な泡状態を維持せず泡が炭酸ガスを保持しなくなる。 The viscosity of the aqueous stock solution at 20 ° C. is preferably in the range of 50 to 500 mPa · s, more preferably in the range of 200 to 300 mPa · s. When the viscosity exceeds 500 mPa · s, the contents attached in the container are not discharged to the end, and the remaining amount increases. Moreover, when the viscosity is less than 50 mPa · s, the foam drips down when foam formed by spraying from a pressure-resistant container equipped with an aerosol valve and a nozzle enclosing an aqueous stock solution and carbon dioxide gas is applied to the skin. The foam does not retain carbon dioxide without maintaining a good foam state.
本願発明に係る血行促進エアゾール組成物には、油成分が配合される。この油成分は、皮膚のエモリエント性を高め使用感を向上させたり、光沢を付与するものである。
この油成分は、水に溶けない液状の成分のことをいい、特に限定されないが、ノルマルパラフィン、イソパラフィン、流動パラフィン、スクワラン、ワセリンなどの炭化水素、ミリスチン酸イソプロピル、オクタン酸セチル、パルミチン酸イソプロピル、ミリスチン酸ミリスチル、ステアリン酸イソセチル、乳酸セチルなどのエステル油、ジメチルシリコーン、環状シリコーンなどのシリコーン油、オリーブ油、ナタネ油、ヒマシ油、ツバキ油、アマニ油、ホホバ油などの油脂、ラウリルアルコール、セチルアルコール、ステアリルアルコール、ベヘニルアルコール、ミリスチルアルコール、オレイルアルコールなどの直鎖アルコールや、モノステアリルグリセリンエーテル、ラノリンアルコール、イソステアリルアルコール、オクチルドデカノールなどの分岐鎖アルコールなどの高級アルコールなどが例示できる。また、これらの油成分の含有量は、水性原液に対して3〜30重量%の範囲が好ましく、更に好ましくは5〜15重量%の範囲である。
The blood circulation promoting aerosol composition according to the present invention contains an oil component. This oil component increases the emollient property of the skin, improves the feeling of use, and imparts gloss.
This oil component refers to a liquid component that does not dissolve in water, and is not particularly limited, but includes hydrocarbons such as normal paraffin, isoparaffin, liquid paraffin, squalane, petrolatum, isopropyl myristate, cetyl octanoate, isopropyl palmitate, Ester oils such as myristyl myristate, isocetyl stearate, cetyl lactate, silicone oils such as dimethyl silicone and cyclic silicone, oils such as olive oil, rapeseed oil, castor oil, camellia oil, linseed oil, jojoba oil, lauryl alcohol, cetyl alcohol , Stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol and other linear alcohols, monostearyl glycerin ether, lanolin alcohol, isostearyl alcohol, octyldede And higher alcohols such as branched chain alcohols such as Nord can be exemplified. Further, the content of these oil components is preferably in the range of 3 to 30% by weight, more preferably in the range of 5 to 15% by weight with respect to the aqueous stock solution.
本願発明に係るエアゾール組成物を構成する水性原液は、水、親水性界面活性剤、増粘剤、油成分とからなるが、本願発明の目的を逸脱しない範囲において、上記成分のほかに、例えば、グリセリンやソルビット液などの保湿剤やエタノールやイソプロパノールなどのアルコール類、香料、dl-α-トコフェロールなどの酸化防止剤、p−ヒドロキシ安息香酸エステルなどの防腐殺菌剤、美白剤や肌荒れ防止剤などの薬剤などを配合することができる。 The aqueous stock solution constituting the aerosol composition according to the present invention comprises water, a hydrophilic surfactant, a thickener, and an oil component, but in the range not departing from the object of the present invention, in addition to the above components, for example, , Moisturizers such as glycerin and sorbit liquids, alcohols such as ethanol and isopropanol, fragrances, antioxidants such as dl-α-tocopherol, antiseptic disinfectants such as p-hydroxybenzoic acid esters, whitening agents and skin roughening agents It is possible to add other drugs.
本願発明に係る血行促進エアゾール組成物は、上述の通り、水性原液と、炭酸ガスとをエアゾール用バルブ及びノズルを備えた耐圧容器に封入してなる組成物であり、本願発明には炭酸ガスが必須成分である。通常噴射剤としてエアゾール製品に用いられる圧縮空気、窒素、酸素などの圧縮ガスは、水性原液に対する溶解性が低いため泡の生成力が弱く良好な泡が形成されず、血行促進効果も得られない。また、同じく通常噴射剤としてエアゾール製品に用いられるLPG(液化石油ガス)などの液化ガスは、血行促進効果が得られないだけではなく、皮膚に対して刺激を与える。 As described above, the blood circulation promoting aerosol composition according to the present invention is a composition in which an aqueous stock solution and carbon dioxide gas are sealed in a pressure-resistant container equipped with an aerosol valve and a nozzle. Carbon dioxide gas is contained in the present invention. It is an essential ingredient. Compressed air, such as compressed air, nitrogen, and oxygen, usually used as aerosols for propellants, have low solubility in aqueous concentrates, so foam formation is weak and good foam is not formed, and blood circulation promotion effects are not obtained. . Similarly, a liquefied gas such as LPG (liquefied petroleum gas), which is usually used for aerosol products as a propellant, not only provides a blood circulation promoting effect but also irritate the skin.
また、エアゾール組成物中の炭酸ガスの含有量は、噴射剤として機能させるために、そして、優れた血行促進効果を発揮させるために、500〜5000ppmの範囲が好ましい。エアゾール製品に関して、炭酸ガスのみを使用したエアゾール製品では原液の内容量は容器の満中量に対して40〜70%である。本願発明において使用する水性原液に溶存している炭酸ガスが500ppmであれば容器内の圧力は35℃で0.2MPaであり、5000ppmであれば容器内の圧力は0.98MPaとなる。日本エアゾール協会の自主基準では圧縮ガスのみを使用したエアゾール製品は、35℃における圧力が1.0MPa未満であれば高圧ガス保安法の適用を受けないと定めている。炭酸ガス含有量が500ppm未満であれば35℃での容器内の圧力が0.2MPa未満となり、エアゾール製品を最後まで使用できず、また、5000ppmを超えると容器内の圧力が1.0MPa以上となり、高圧ガス保安法の適用を受け、エアゾール製品とはならない。よって、後述する耐圧容器の圧力は、35℃において0.2〜1.0MPa未満の範囲であることが好ましく、0.4〜0.8MPaの範囲であることがより好ましい。また、炭酸ガスによる血行促進効果を発揮させるためには、エアゾール組成物のpHは、炭酸ガスが溶存した状態で7.0以下であればよく、肌に使用する製品であることからpH3.0〜7.0の範囲であることが好ましく、pH4.0〜6.0の範囲であることがより好ましい。上記範囲内にpHを調製するために、クエン酸ナトリウムなどのpH調整剤を配合してもよい。また、皮膚への刺激を与えず、かつ本願発明において弊害を生じない範囲において、炭酸ガスに加えて、通常噴射剤としてエアゾール製品に用いられるLPG(液化石油ガス)を噴射剤として用いてもよく、圧縮空気、窒素、酸素などの圧縮ガスについても、本願発明の目的を逸脱しない範囲において、炭酸ガスに加えて噴射剤として用いてもよい。 Further, the carbon dioxide content in the aerosol composition is preferably in the range of 500 to 5000 ppm in order to function as a propellant and to exert an excellent blood circulation promoting effect. Regarding the aerosol product, in the aerosol product using only carbon dioxide, the content of the stock solution is 40 to 70% with respect to the full amount of the container. If the carbon dioxide dissolved in the aqueous stock solution used in the present invention is 500 ppm, the pressure in the container is 0.2 MPa at 35 ° C., and if it is 5000 ppm, the pressure in the container is 0.98 MPa. The Japan Aerosol Association voluntary standards stipulate that aerosol products that use only compressed gas are not subject to the High Pressure Gas Safety Law if the pressure at 35 ° C. is less than 1.0 MPa. If the carbon dioxide content is less than 500 ppm, the pressure in the container at 35 ° C. will be less than 0.2 MPa, and the aerosol product cannot be used to the end, and if it exceeds 5000 ppm, the pressure in the container will be 1.0 MPa or more. Under the application of the High Pressure Gas Safety Law, it will not be an aerosol product. Therefore, the pressure of the pressure vessel described later is preferably in the range of 0.2 to less than 1.0 MPa at 35 ° C., and more preferably in the range of 0.4 to 0.8 MPa. Moreover, in order to exhibit the blood circulation promotion effect by a carbon dioxide gas, pH of an aerosol composition should just be 7.0 or less in the state which a carbon dioxide gas dissolved, and since it is a product used for skin, it is pH3.0. It is preferably in the range of -7.0, more preferably in the range of pH 4.0-6.0. In order to adjust the pH within the above range, a pH adjusting agent such as sodium citrate may be blended. In addition to carbon dioxide, LPG (liquefied petroleum gas), which is usually used in aerosol products as a propellant, may be used as a propellant as long as it does not irritate the skin and does not cause harmful effects in the present invention. Compressed gas such as compressed air, nitrogen, and oxygen may also be used as a propellant in addition to carbon dioxide gas without departing from the object of the present invention.
上記水性原液と、上記炭酸ガスとは、エアゾール用バルブ及びノズルを備えた耐圧容器に封入される。その封入方法には特に制限はなく、例えば、水性原液の各成分を撹拌混合し、乳化させて調整したのち、耐圧容器に充填し、さらに圧縮炭酸ガスを耐圧容器に封入する方法などを採用することができる。また、用いられる耐圧容器は、封入される炭酸ガスの内圧に耐え封入された内容物を泡状にして吐出できるものであればよく、アルミやブリキなどの金属製のほか、ポリアセタールやポリカーボネート等の合成樹脂などの容器を利用することができる。さらに、吐出口となるノズル径やノズルの長さについても特に制限はなく、封入された内容物を泡状にして吐出できるのに適した種々の大きさや長さのものを使用することができる。 The aqueous stock solution and the carbon dioxide gas are enclosed in a pressure-resistant container equipped with an aerosol valve and a nozzle. There is no particular limitation on the sealing method, and for example, a method in which each component of the aqueous stock solution is stirred and mixed, emulsified and adjusted, then filled in a pressure resistant container, and further compressed carbon dioxide gas is sealed in the pressure resistant container is adopted. be able to. In addition, the pressure vessel to be used is not limited as long as it can withstand the internal pressure of the enclosed carbon dioxide gas and can discharge the enclosed contents in the form of foam. In addition to metal such as aluminum and tinplate, polyacetal, polycarbonate, etc. A container such as a synthetic resin can be used. Furthermore, there are no particular restrictions on the nozzle diameter and nozzle length that serve as the discharge port, and it is possible to use various sizes and lengths suitable for allowing the enclosed contents to be discharged in the form of bubbles. .
本願発明に係る血行促進エアゾール組成物は良好な泡を形成し、皮膚に塗布した後20秒以内に皮膚と接触した箇所の泡が消泡し始めるが、形成した良好な泡状態を少なくとも1分間は維持する。よって、形成された泡に含まれる炭酸ガスも少なくとも1分間は保持され、その間に塗布された皮膚に対して血行促進効果を発揮する。また、本願発明に係る血行促進エアゾール組成物を皮膚に対して継続的に使用することによって、皮膚の血流改善効果も期待できる。 The blood circulation-promoting aerosol composition according to the present invention forms a good foam, and the foam in the portion in contact with the skin starts to disappear within 20 seconds after being applied to the skin, but the good foam state formed is at least 1 minute. Maintain. Therefore, the carbon dioxide gas contained in the formed foam is also held for at least 1 minute, and exerts a blood circulation promoting effect on the skin applied during that time. Moreover, the blood flow improvement effect of skin can also be expected by continuously using the blood circulation promoting aerosol composition according to the present invention on the skin.
本願発明に係る血行促進エアゾール組成物は、例えば、化粧水や乳液、美容液、クレンジング剤などの基礎化粧料、シャンプーやコンディショナー、育毛剤などの頭髪・頭皮用化粧料、ボディソープなどのボディケア化粧料などとして使用することができる。 The blood circulation promoting aerosol composition according to the present invention includes, for example, basic cosmetics such as lotion, milky lotion, cosmetic liquid and cleansing agent, shampoo and conditioner, cosmetics for hair and scalp such as hair restorer, and body care such as body soap. It can be used as cosmetics.
以下に実施例を挙げて本願発明を詳細に説明するが、本願発明はこれらの実施例によって何ら限定されるものではない。 Hereinafter, the present invention will be described in detail with reference to examples, but the present invention is not limited to these examples.
(実施例1〜3)
表1に示す各成分を撹拌混合し、乳化させて水性原液を調製し、エアゾール用バルブ及びノズルを備えた耐圧容器に充填した後、同じく表1に示す配合割合により炭酸ガスを封入して血行促進エアゾール組成物を得た。得られた血行促進エアゾール組成物を、下記に示す方法により、泡安定性、皮膚刺激、皮膚紅潮について評価した。
(Examples 1-3)
Each component shown in Table 1 is stirred and mixed, emulsified to prepare an aqueous stock solution, filled into a pressure-resistant container equipped with an aerosol valve and a nozzle, and then filled with carbon dioxide at the blending ratio shown in Table 1 for blood circulation. An accelerated aerosol composition was obtained. The obtained blood circulation promoting aerosol composition was evaluated for foam stability, skin irritation, and flushing by the following methods.
(粘度測定)
水性原液の粘度測定には、B形粘度計(形式BM)(株式会社東京計器製)を用いた。測定温度は20℃とし、No.2ローターを使用し、ローター回転数30rpmで測定開始後60秒の粘度を測定した。
(pH測定)
本願発明に係る血行促進エアゾール組成物のpH測定には、pHMETER(M−13型)(HORIBA製)を用いた。測定温度は20℃とした。
(Viscosity measurement)
A B-type viscometer (type BM) (manufactured by Tokyo Keiki Co., Ltd.) was used to measure the viscosity of the aqueous stock solution. The measurement temperature was 20 ° C. Using two rotors, the viscosity was measured 60 seconds after the start of measurement at a rotor rotation speed of 30 rpm.
(PH measurement)
PHMETER (M-13 type) (manufactured by HORIBA) was used for pH measurement of the blood circulation promoting aerosol composition according to the present invention. The measurement temperature was 20 ° C.
(評価方法)
20〜50代の男女20名で下記試験を実施して評価した。
(1)泡安定性
皮膚上に3cmφとなるように耐圧容器からの噴射により形成された各試料の泡を塗布し、室温(23〜27℃)で2分間放置して泡の状態を評価した。
◎:泡を形成し、2分間その泡状態を維持する
○:泡を形成するが、1分以上2分未満でたれてしまう
△:泡を形成するが、1分未満でたれてしまう
×:泡を形成しない
(2)皮膚刺激
皮膚上に3cmφとなるように耐圧容器からの噴射により形成された各試料の泡を塗布し、2分間放置して拭き取った。その後、皮膚への刺激に関してモニター調査を行った。
◎:18名以上が刺激はないと回答した。
○:14〜17名が刺激はないと回答した。
△:10〜13名が刺激はないと回答した。
×:9名以下が刺激はないと回答した。
(3)皮膚紅潮
皮膚上に3cmφとなるように耐圧容器からの噴射により形成された各試料の泡を塗布、2分間放置して、拭き取った後の皮膚の状態(皮膚紅潮)を目視で観察した。皮膚紅潮により血行促進効果を評価した。
◎:18名以上が紅潮を認めた
○:14〜17名が紅潮を認めた
△:10〜13名が紅潮を認めた
×:9名以下が紅潮を認めた
(Evaluation methods)
The following tests were conducted and evaluated by 20 men and women in their 20s and 50s.
(1) Foam stability The foam of each sample formed by spraying from a pressure-resistant container was applied to the skin so as to have a diameter of 3 cmφ, and allowed to stand at room temperature (23-27 ° C.) for 2 minutes to evaluate the state of the foam. .
A: Bubbles are formed, and the bubble state is maintained for 2 minutes. O: Bubbles are formed, but they are dripped for 1 minute or more and less than 2 minutes. Δ: Bubbles are formed, but they are dripped in less than 1 minute. No foam is formed (2) Skin irritation The foam of each sample formed by spraying from a pressure-resistant container is applied on the skin so as to have a diameter of 3 cmφ, and left for 2 minutes to wipe off. Thereafter, a monitor survey was conducted for skin irritation.
A: 18 or more responded that there was no irritation.
○: 14 to 17 people answered that there was no irritation.
Δ: 10 to 13 persons answered that there was no irritation.
×: Nine or less responded that there was no irritation.
(3) Skin flushing Apply the foam of each sample formed by spraying from the pressure-resistant container so that it becomes 3 cmφ on the skin, leave it for 2 minutes, and visually observe the skin condition (skin flushing) after wiping off did. Blood circulation promotion effect was evaluated by skin flushing.
◎: 18 or more people observed flushing ○: 14-17 people observed flushing △: 10-13 people observed flushing ×: 9 or less people observed flushing
(比較例1〜5)
実施例1〜実施例3の比較のために、炭酸ガスのほかにLPG(液化石油ガス)を加えて配合したもの、増粘剤を配合しなかったもの、エタノールを配合したもの、油成分や親水性界面活性剤の量を増減させたものを上記実施例1〜実施例3と同様の方法で調製し、これを比較例1〜比較例5とした。これらの比較例1〜比較例5の成分及び試験結果を表1に示す。
(Comparative Examples 1-5)
For comparison between Example 1 and Example 3, in addition to carbon dioxide, LPG (liquefied petroleum gas) was added and blended, thickener was not blended, ethanol was blended, oil components and What increased / decreased the amount of hydrophilic surfactant was prepared by the method similar to the said Example 1- Example 3, and this was made into Comparative Example 1- Comparative Example 5. The components and test results of these Comparative Examples 1 to 5 are shown in Table 1.
表1に示すように、実施例1〜3は、室温(23〜27℃)での泡安定性が良好であり、かつ皮膚紅潮が認められたことから、炭酸ガスによる血行促進効果を確認することができた。また、皮膚刺激性については認められなかった。実施例1と実施例2においては水性原液に対する油成分の配合割合に差があるが、油成分に対して適量の親水性界面活性剤を配合することによって良好な結果が得られた。
実施例1の炭酸ガスのほかにLPG(液化石油ガス)を加えて配合した比較例1は、室温(23〜27℃)での泡安定性が良好であったが皮膚紅潮が認められず、LPGによる皮膚刺激性が被験者の半数以上で認められた。また、エタノールを水性原液中の半分以上配合し、かつ増粘剤を配合しなかった比較例3は、泡を形成せず、増粘剤の有無や油成分、親水性界面活性剤の量を増減させた比較例2、比較例4〜比較例5は、皮膚刺激性は認められなかったものの泡安定性が悪く、かつ皮膚紅潮が認められなかった。
よって、水、親水性界面活性剤、増粘剤、油成分を含む水性原液と炭酸ガスとをエアゾール用バルブ及びノズルを備えた耐圧容器に封入してなるエアゾール組成物は、泡の状態が良好であり、かつ皮膚への刺激がなく、皮膚に塗布した後20秒以内に皮膚と接触した箇所の炭酸ガスを含む泡が消泡し始めるが、少なくとも1分間は泡状態が保持され、その間に炭酸ガスが皮膚の内部に浸透することによって優れた血行促進効果が得られることが確認できた。
As shown in Table 1, Examples 1 to 3 have good foam stability at room temperature (23 to 27 ° C.), and skin flushing was observed, confirming the blood circulation promoting effect by carbon dioxide. I was able to. Further, no skin irritation was observed. In Example 1 and Example 2, there is a difference in the blending ratio of the oil component to the aqueous stock solution, but good results were obtained by blending an appropriate amount of the hydrophilic surfactant with respect to the oil component.
In Comparative Example 1 in which LPG (liquefied petroleum gas) was added in addition to the carbon dioxide gas of Example 1, the foam stability at room temperature (23 to 27 ° C.) was good, but no skin flushing was observed, Skin irritation by LPG was observed in more than half of the subjects. Moreover, the comparative example 3 which mix | blended ethanol more than half in the aqueous | water-based stock solution, and did not mix | blend a thickener does not form a foam, the presence or absence of a thickener, an oil component, and the quantity of hydrophilic surfactant. In Comparative Example 2 and Comparative Examples 4 to 5 which were increased or decreased, although the skin irritation was not observed, the foam stability was poor and skin flushing was not observed.
Therefore, an aerosol composition in which water, a hydrophilic surfactant, a thickener, an aqueous stock solution containing an oil component, and carbon dioxide gas are sealed in a pressure-resistant container equipped with an aerosol valve and a nozzle have a good foam state. The foam containing carbon dioxide gas at the point of contact with the skin starts to disappear within 20 seconds after being applied to the skin without any irritation to the skin, but the foam state is maintained for at least 1 minute. It was confirmed that an excellent blood circulation promoting effect was obtained by the penetration of carbon dioxide into the skin.
Claims (4)
上記耐圧容器からの噴射により形成された泡を皮膚に塗布した後、20秒以内に皮膚と接触した箇所の泡が消泡し始め、少なくとも1分間は泡状態を維持するものであり、
その泡状態が維持される間に塗布部位に対して血行促進効果を発揮することを特徴とする血行促進エアゾール組成物。 In an aerosol composition in which water, a hydrophilic surfactant, a thickener, a stock solution containing an oil component, and carbon dioxide gas are sealed in a pressure-resistant container equipped with an aerosol valve and a nozzle,
After the foam formed by spraying from the pressure vessel is applied to the skin, the foam at the point of contact with the skin within 20 seconds begins to disappear, and the foam state is maintained for at least 1 minute.
A blood circulation promoting aerosol composition characterized by exerting a blood circulation promoting effect on an application site while the foam state is maintained.
上記原液中の上記油成分含有量が3〜30重量%であり、
上記エアゾール組成物中の上記炭酸ガス含有量が500〜5000ppmであることを特徴とする請求項1に記載の血行促進エアゾール組成物。 The HLB of the hydrophilic surfactant is 10 to 19, and the hydrophilic surfactant content in the stock solution is 0.1 to 15% by weight;
The oil component content in the stock solution is 3 to 30% by weight,
The blood circulation promoting aerosol composition according to claim 1, wherein the carbon dioxide gas content in the aerosol composition is 500 to 5000 ppm.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010244906A JP2012097013A (en) | 2010-11-01 | 2010-11-01 | Blood circulation promoting aerosol composition |
| CN2011101787400A CN102462630A (en) | 2010-11-01 | 2011-06-20 | Aerosol composition for promoting blood circulation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010244906A JP2012097013A (en) | 2010-11-01 | 2010-11-01 | Blood circulation promoting aerosol composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2012097013A true JP2012097013A (en) | 2012-05-24 |
Family
ID=46066941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010244906A Pending JP2012097013A (en) | 2010-11-01 | 2010-11-01 | Blood circulation promoting aerosol composition |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2012097013A (en) |
| CN (1) | CN102462630A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014201523A (en) * | 2013-04-01 | 2014-10-27 | 日進化学株式会社 | Aerosol composition and method of using the same |
| JP2015223541A (en) * | 2014-05-27 | 2015-12-14 | 株式会社ワンエイト | Device for supplying reduced hydrogen water and carbonic acid |
| WO2017086291A1 (en) * | 2015-11-20 | 2017-05-26 | 株式会社マンダム | Composition for scalp, cosmetic for scalp, and method for applying composition for scalp |
| JP2017125003A (en) * | 2015-05-29 | 2017-07-20 | 花王株式会社 | Aerosol cosmetics |
| JP2018172317A (en) * | 2017-03-31 | 2018-11-08 | 株式会社東洋新薬 | Hair-growing composition |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109394551B (en) * | 2015-12-28 | 2022-08-02 | 花王株式会社 | Aerosol cosmetic product |
| CN107913198A (en) * | 2018-01-03 | 2018-04-17 | 中山市天图精细化工有限公司 | The micro-nano elite of carbonic acid nourishes aerosol |
| CN114599333B (en) * | 2019-11-01 | 2024-09-10 | 株式会社资生堂 | Method for using ultra-fine bubbles |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003300810A (en) * | 2003-06-16 | 2003-10-21 | Kao Corp | Aerosol composition |
| JP2005002046A (en) * | 2003-06-12 | 2005-01-06 | Kao Corp | Effervescent skin coating agent |
| JP2009269914A (en) * | 2008-04-11 | 2009-11-19 | Kao Corp | Foamed skin liniment |
| JP2009292740A (en) * | 2008-06-03 | 2009-12-17 | Pola Chem Ind Inc | Cosmetic for blood circulation promotion |
| JP2010030945A (en) * | 2008-07-28 | 2010-02-12 | Pola Chem Ind Inc | Foam cosmetic having warm feeling |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09268118A (en) * | 1996-04-01 | 1997-10-14 | Kao Corp | Skin color improving beauty agent |
| JP3668161B2 (en) * | 2000-09-28 | 2005-07-06 | 株式会社ヒロマイト | Method for producing carbonic acid transdermal composition |
| JP4099129B2 (en) * | 2003-09-17 | 2008-06-11 | 花王株式会社 | Carbon dioxide supply skin cosmetics |
| EP1849472B1 (en) * | 2005-01-28 | 2016-08-10 | Neochemir, Inc. | Composition for preparing carbon dioxide preparation for external use |
| EP1752128B1 (en) * | 2005-07-18 | 2015-01-14 | Wella GmbH | Aerosol creme mousse, method of treating hair and use |
-
2010
- 2010-11-01 JP JP2010244906A patent/JP2012097013A/en active Pending
-
2011
- 2011-06-20 CN CN2011101787400A patent/CN102462630A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005002046A (en) * | 2003-06-12 | 2005-01-06 | Kao Corp | Effervescent skin coating agent |
| JP2003300810A (en) * | 2003-06-16 | 2003-10-21 | Kao Corp | Aerosol composition |
| JP2009269914A (en) * | 2008-04-11 | 2009-11-19 | Kao Corp | Foamed skin liniment |
| JP2009292740A (en) * | 2008-06-03 | 2009-12-17 | Pola Chem Ind Inc | Cosmetic for blood circulation promotion |
| JP2010030945A (en) * | 2008-07-28 | 2010-02-12 | Pola Chem Ind Inc | Foam cosmetic having warm feeling |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014201523A (en) * | 2013-04-01 | 2014-10-27 | 日進化学株式会社 | Aerosol composition and method of using the same |
| JP2015223541A (en) * | 2014-05-27 | 2015-12-14 | 株式会社ワンエイト | Device for supplying reduced hydrogen water and carbonic acid |
| JP2017125003A (en) * | 2015-05-29 | 2017-07-20 | 花王株式会社 | Aerosol cosmetics |
| WO2017086291A1 (en) * | 2015-11-20 | 2017-05-26 | 株式会社マンダム | Composition for scalp, cosmetic for scalp, and method for applying composition for scalp |
| KR20180026535A (en) * | 2015-11-20 | 2018-03-12 | 가부시키가이샤 만다무 | Composition for scalp, cosmetic composition for scalp and application method of composition for scalp |
| JPWO2017086291A1 (en) * | 2015-11-20 | 2018-04-05 | 株式会社マンダム | Composition for scalp, cosmetics for scalp and method for applying composition for scalp |
| KR102062200B1 (en) * | 2015-11-20 | 2020-01-03 | 가부시키가이샤 만다무 | Scalp composition, scalp cosmetic and coating method |
| JP2018172317A (en) * | 2017-03-31 | 2018-11-08 | 株式会社東洋新薬 | Hair-growing composition |
| JP2021143197A (en) * | 2017-03-31 | 2021-09-24 | 株式会社東洋新薬 | Composition for hair growth |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102462630A (en) | 2012-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012097013A (en) | Blood circulation promoting aerosol composition | |
| KR101604776B1 (en) | Surfactant-free foam formulations | |
| KR101528018B1 (en) | An Aerosol Shave Composition Comprising a Hydrophobical Agent Forming At Least One Microdroplet | |
| JP5841722B2 (en) | 2-component foamable aerosol products | |
| AU2007356328A1 (en) | Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses | |
| JP2002012513A (en) | Urea-containing whipped cosmetic | |
| JP5781783B2 (en) | Aerosol composition | |
| JP2009269914A (en) | Foamed skin liniment | |
| JP2007528896A (en) | Shaving gel products | |
| JP4971713B2 (en) | Aerosol composition and aerosol product comprising the aerosol composition | |
| JPH09110636A (en) | Foam cosmetic for skin or hair | |
| JP5180601B2 (en) | Aerosol composition | |
| JP6163340B2 (en) | Aerosol composition and method of use | |
| JP2005002046A (en) | Effervescent skin coating agent | |
| JP2018027907A (en) | Oil foam aerosol composition | |
| JP7720150B2 (en) | Foaming aerosol composition and aerosol product | |
| JP5044106B2 (en) | Aerosol composition for human body containing vitamins | |
| JP2009155225A (en) | Oil-containing cosmetic composition | |
| KR20140094187A (en) | Surfactant-free self-foaming cosmetic composition | |
| JP7553274B2 (en) | Aerosol composition for disinfection | |
| JP6991818B2 (en) | Effervescent aerosol composition | |
| US10413488B2 (en) | Aerosol oil foam compositions comprising a triglyceride-based oil and surfactant | |
| JP7418920B2 (en) | Aerosol type hair remover | |
| CN110520098B (en) | Temperature-sensitive composition and aerosol preparation containing same | |
| JP5140298B2 (en) | Spray composition and spray product comprising said composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130716 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20140319 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140401 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140529 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20141202 |